Effects of prostaglandin E1 therapy on cyclosporine A and creatinine levels after orthotopic heart transplantation.
Iberer
F
F
Department of Transplantation, Karl-Franzens University, Graz, Austria.
Vujicic
R
R
Rödl
S
S
Wasler
A
A
Sabin
K
K
Koshsorur
A
A
Allmayer
T
T
Auer
T
T
Petutschnigg
B
B
Tscheliessnigg
K H
KH
D000293:Adolescent; D000328:Adult; D000527:Alprostadil / Q000627:therapeutic use*; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D003404:Creatinine / Q000097:blood* / Q000493:pharmacokinetics; D016572:Cyclosporine / Q000097:blood* / Q000627:therapeutic use; D016027:Heart Transplantation / Q000276:immunology / Q000502:physiology*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D014019:Tissue Donors
D000961:Antilymphocyte Serum; D016572:Cyclosporine; D003404:Creatinine; D000527:Alprostadil; D001379:Azathioprine; D008775:Methylprednisolone